Hans Peter Hasler's Net Worth
$20.9 Million
Who is Hans Peter Hasler?
Hans Peter Hasler has an estimated net worth of $20.9 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., Patheon N.V., Gain Therapeutics, Inc., and Minerva Neurosciences, Inc..
SEC CIK
Hans Peter Hasler's CIK is 0001226286
Past Insider Trading and Trends
2007 was Hans Peter Hasler's most active year for acquiring shares with 11 total transactions. Hans Peter Hasler's most active month to acquire stocks was the month of January. 2008 was Hans Peter Hasler's most active year for disposing of shares, totalling 67 transactions. Hans Peter Hasler's most active month to dispose stocks was the month of March. 2007 saw Hans Peter Hasler paying a total of $8,429,577.50 for 267,173 shares, this is the most they've acquired in one year. In 2007 Hans Peter Hasler cashed out on 365,784 shares for a total of $13,433,271.59, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN IDEC INC. (BIIB) Snapshot price: $241.69
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +60.81% | 20.14K |
—
|
—
| 53.26K |
Feb 24
| |||
Form 4
| -30.33% | -11.69K |
$50.94 | -$595,672.29 | 26.86K |
Scheduled
|
Feb 19
| ||
Form 4
| -1.65% | -754.00 |
$52.61 | -$39,667.94 | 44.81K |
Feb 12
| |||
Form 4
| -10.13% | -5.13K |
$50.77 | -$260,699.33 | 45.57K |
Scheduled
|
Feb 11
| ||
Form 4
| +11.27% | 5.13K |
$52.48 | -$17,370.88 | 50.7K |
Feb 6
| |||
Form 4
| -1.82% | -845.00 |
$44.31 | -$37,445.92 | 45.57K |
Scheduled
|
Nov 6
| ||
Form 4
| -0.12% | -55.00 |
$42.55 | -$2,340.25 | 46.41K |
Nov 1
| |||
Form 4
|
—
|
0
|
$59.31 | -$259,000.00 | 46.47K |
Scheduled
|
Jul 22
| ||
Form 4
| +10.46% | 4.4K |
—
|
—
| 46.47K |
Jun 2
| |||
Form 4
| -15.41% | -7.66K |
$64.53 | -$494,485.61 | 42.07K |
Scheduled
|
Apr 8
| ||
Form 4
| -6.99% | -3.74K |
$54.04 | -$584,950.37 | 49.73K |
Scheduled
|
Apr 8
| ||
Form 4
| +46.36% | 16.94K |
$60.56 | -$24,466.24 | 53.47K |
Feb 12
| |||
Form 4
| +16.36% | 5.14K |
$60.52 | -$20,032.12 | 36.53K |
Feb 6
| |||
Form 4
| +9.41% | 2.7K |
—
|
—
| 31.39K |
Nov 1
| |||
Form 4
|
—
|
0
|
$67.61 | -$3,128,662.50 | 28.7K |
Scheduled
|
Oct 15
| ||
Form 4
|
—
|
0
|
$54.24 | -$204,500.00 | 28.7K |
Scheduled
|
Aug 30
| ||
Form 4
|
—
|
0
|
$53.50 | -$412,120.00 | 28.7K |
Scheduled
|
Aug 27
| ||
Form 4
|
—
|
0
|
$47.45 | -$690,000.00 | 28.7K |
Scheduled
|
Jul 25
| ||
Form 4
| -17.08% | -5.91K |
$44.48 | -$262,870.30 | 28.7K |
Scheduled
|
Mar 20
| ||
Form 4
| +20.60% | 5.91K |
$44.11 | -$13,894.65 | 34.6K |
Mar 14
| |||
Form 4
| -15.32% | -5.19K |
$49.22 | -$255,431.04 | 28.7K |
Scheduled
|
Feb 13
| ||
Form 4
| +144.04% | 20K |
—
|
—
| 33.88K |
Feb 12
| |||
Form 4
| +51.62% | 4.73K |
$48.94 | -$36,215.60 | 13.88K |
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Patheon N.V. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -16.86K |
$35.00 | -$590,240.00 |
0
|
Aug 29
| |||
Form 4
| +73.18% | 7.13K |
—
|
—
| 16.86K |
Mar 23
| |||
Form 4
| +81.80% | 9.74K |
$25.61 | -$55,496.87 | 21.64K |
Nov 1
| |||
Form 4
|
∞
| 11.9K |
—
|
—
| 11.9K |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gain Therapeutics, Inc. (GANX) Snapshot price: $4.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Minerva Neurosciences, Inc. (NERV) Snapshot price: $11.185
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
∞
| 10K |
$5.60 | $56,000.00 | 10K |
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||